| | | | | | | | | | |
|
|
| Dockets Entered
On January 9, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1995N-0309
|
| CGMPs for the Production of Infant Formula
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| 1998P-1194
|
| Withdrawal NADA Approval for Posilac - rBGH
|
|
|
| 2000P-0685
|
| Revise of Yogurt Standards
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
| 2002N-0058
|
| Pediculicide Drug Products for OTC Human Use
|
|
|
| 2002N-0277
|
| Bioterrorism; Establishment & Maintenance of Records
|
|
|
| 2002N-0278
|
| Bioterrorism; Prior Notice of Imported Food Shipments
|
|
|
| 2002P-0489
|
| Request Revision of CVM's Bioequivalence Guidelines
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
| 2003D-0504
|
| Bundling Multiple Devices in a Single Application; Draft Guidance for Industry and FDA; Availability
|
|
|
| 2003D-0562
|
| Compliance Policy Guide Sec.110.300 b
|
|
|
| 2003P-0362
|
| Over-the-counter Hearing Aids
|
|
|
| 2003P-0530
|
| Silicone Gel-filled Breast Implants
|
|
|
| 2004P-0013
|
| Review safety of Nutropin Depot Injection, issue direction to Genentech Inc. to add warnings regarding diabetes in their safety literature, and consider amending 21 CFR 314.80(e) Postmarketing studies
|
|
|
|
| 2004P-0015
|
| Deny approval of any New Drug Application ( NDA ) for recombinant salmon calcitonin (rsCT ) nasal spray
|
|
|
| 1995N-0309
|
| CGMPs for the Production of Infant Formula
|
|
|
| C
26
|
| American Academy of Pediatrics (AAP)
|
| Vol #:
|
| 9
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET
12202
|
| New Chapter, Inc.
|
| Vol #:
|
| 97
|
|
|
| LET
12203
|
| New Chapter, Inc.
|
| Vol #:
|
| 97
|
|
|
| LET
12204
|
| New Chapter, Inc.
|
| Vol #:
|
| 97
|
|
|
| LET
12205
|
| Solstice Medicine Company
|
| Vol #:
|
| 97
|
|
|
| LET
12206
|
| Solstice Medicine Company
|
| Vol #:
|
| 97
|
|
|
| LET
12207
|
| Solstice Medicine Company
|
| Vol #:
|
| 97
|
|
|
| LET
12208
|
| Solstice Medicine Company
|
| Vol #:
|
| 97
|
|
|
| LET
12209
|
| Solstice Medicine Company
|
| Vol #:
|
| 97
|
|
|
| LET
12210
|
| Solstice Medicine Company
|
| Vol #:
|
| 97
|
|
|
| LET
12211
|
| Solstice Medicine Company
|
| Vol #:
|
| 97
|
|
|
| LET
12212
|
| Solstice Medicine Company
|
| Vol #:
|
| 97
|
|
|
| LET
12213
|
| Solstice Medicine Company
|
| Vol #:
|
| 97
|
|
|
| LET
12214
|
| Source Naturals
|
| Vol #:
|
| 97
|
|
| | | | | | | | |
|
|
| C
326
|
| Sexual Assault and Violence Intervention Program (SAVI)
|
| Vol #:
|
| 125
|
|
|
| C
327
|
| State of Washington Dept of Health
|
| Vol #:
|
| 125
|
|
|
| C 328
|
| S. Dubinsky
|
| Vol #:
|
| 125
|
|
|
| C
329
|
| Operation Outcry: Silent No More
|
| Vol #:
|
| 125
|
|
|
| C 330
|
| G. Mueller
|
| Vol #:
|
| 125
|
|
|
| C 331
|
| B. Boone
|
| Vol #:
|
| 125
|
|
|
| C 332
|
| M. O'Dell
|
| Vol #:
|
| 125
|
|
|
| C
333
|
| American Academy of Family Physicians
|
| Vol #:
|
| 125
|
|
|
| C 334
|
| M.L. Palazzo
|
| Vol #:
|
| 125
|
|
|
| C
335
|
| Form Letter
|
| Vol #:
|
| 126
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
| C 1354
|
| C. Cogle
|
| Vol #:
|
| 233
|
|
|
| 2002N-0058
|
| Pediculicide Drug Products for OTC Human Use
|
|
|
| SUP
1
|
| Supplemental Material
|
| Vol #:
|
| 1
|
|
|
| 2002N-0277
|
| Bioterrorism; Establishment & Maintenance of Records
|
|
|
| C
105
|
| Comite Interprofessionnel Du Vin de Champagne
|
| Vol #:
|
| 16
|
|
|
| C
106
|
| Fountain fruit Corporation
|
| Vol #:
|
| 16
|
|
|
| 2002N-0278
|
| Bioterrorism; Prior Notice of Imported Food Shipments
|
|
|
| C
287
|
| Department of Defense (DoD)
|
| Vol #:
|
| 22
|
|
|
| 2002P-0489
|
| Request Revision of CVM's Bioequivalence Guidelines
|
|
|
| PDN
1
|
| HFC-1 to James H. Schafer, D.V.M.
|
| Vol #:
|
| 1
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
| C
56
|
| Form Letters
|
| Vol #:
|
| 4
|
|
|
| C
57
|
| ECR Pharmaceuticals
|
| Vol #:
|
| 5
|
|
|
| C
58
|
| T. Kerr
|
| Vol #:
|
| 5
|
|
|
| C
59
|
| Adams Laboratories, Inc.
|
| Vol #:
|
| 4
|
|
|
| C
60
|
| Healthpoint, Ltd
|
| Vol #:
|
| 5
|
|
|
| 2003D-0504
|
| Bundling Multiple Devices in a Single Application; Draft Guidance for Industry and FDA; Availability
|
|
|
| C
1
|
| Olympus America, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2003D-0562
|
| Compliance Policy Guide Sec.110.300 b
|
|
|
| C 1
|
| M.L. Sotelo
|
| Vol #:
|
| 1
|
|
|
| 2003P-0362
|
| Over-the-counter Hearing Aids
|
|
| | | | | | | | |
|
|
| C
7
|
| Tru Hearing
|
| Vol #:
|
| 1
|
|
|
| 2003P-0530
|
| Silicone Gel-filled Breast Implants
|
|
|
| C
2
|
| Action Against Silicone Gel-UK
|
| Vol #:
|
| 1
|
|
|
| C
3
|
| Secretary Dutch Silicone Support Group,St.SVS
|
| Vol #:
|
| 1
|
|
|
| 2004P-0013
|
| Review safety of Nutropin Depot Injection, issue direction to Genentech Inc. to add warnings regarding diabetes in their safety literature, and consider amending 21 CFR 314.80(e) Postmarketing studies
|
|
|
|
|
|
|
| ACK
1
|
| HFA-305 to Consumer
|
| Vol #:
|
| 1
|
|
|
| CP
1
Attachment
1, 2, 3,
4, 5,
6, 7,
8, 9,
10, 11,
12, 13
|
| Consumer
|
| Vol #:
|
| 1
|
|
|
| 2004P-0015
|
| Deny approval of any New Drug Application ( NDA ) for recombinant salmon calcitonin (rsCT ) nasal spray
|
|
|
| ACK
1
|
| HFA-305 to Buc & Beardsley
|
| Vol #:
|
| 1
|
|
|
| CP
1
|
| Buc & Beardsley
|
| Vol #:
|
| 1
|
|